Skip to main content
UG
NASDAQ Industrial Applications And Services

Annual Report Reveals 13% Sales Drop, 35% Net Income Decline for Fiscal 2025

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Household Product Stocks · Consumer
Sentiment info
Negative
Importance info
8
Price
$6.25
Mkt Cap
$28.714M
52W Low
$5.575
52W High
$9.88
52W Position info
12% above low
Off High info
37% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

UG is trading near its 52-week low of $5.575 (12% above the low) on light trading volume (0.1× avg).

Summary

United Guardian Inc. reported a 13% decrease in net sales and a 35% drop in net income for fiscal year 2025, primarily due to a sharp decline in cosmetic ingredient sales, despite growth in other segments.


Key Events · Earnings and Guidance · UG

  • Significant Revenue Decline

    Net sales decreased by 13% to $10.5 million in 2025 from $12.2 million in 2024.

  • Sharp Drop in Net Income and EPS

    Net income fell by 35% to $2.1 million ($0.46 EPS) in 2025 from $3.25 million ($0.71 EPS) in 2024.

  • Cosmetic Sales Plunge

    Sales of cosmetic ingredients decreased by 45%, largely due to a 54% drop in sales to the largest distributor, impacted by decreased demand and overstocking.

  • New Distribution Agreement for Sexual Wellness Products

    In January 2026, the company entered a new distribution agreement with Brenntag Specialties for its Natrajel sexual wellness ingredients in North America and Lubrajel/Natrajel products in France.


Analysis · UG · Industrial Applications And Services

United Guardian Inc.'s annual report for fiscal year 2025 confirms a significant downturn in financial performance, with net sales decreasing by 13% and net income falling by 35%. This decline was primarily driven by a substantial 45% drop in cosmetic ingredient sales, particularly to its largest distributor, due to decreased demand in Asia and overstocking issues. While pharmaceutical sales saw a 15% increase and medical lubricants grew by 4%, these gains were insufficient to offset the broader decline. The company also disclosed a new distribution agreement for its sexual wellness products and a $300,000 settlement with a contract manufacturer, both expected to positively impact Q1 2026. However, the immediate financial results and a decrease in gross profit margin from 53% to 49% present a challenging picture for investors. The company's qualification as a 'specified small manufacturer' for Medicare Part D offers short-term rebate relief but anticipates significantly higher liabilities by 2031.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, UG was trading at $6.25 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $28.7M. The 52-week trading range was $5.58 to $9.88. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

UG - Latest Insights

UG
Nov 09, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
7
UG
Aug 07, 2026, 10:42 AM EDT
Source: Reuters
Importance Score:
7
UG
May 12, 2026, 9:00 AM EDT
Filing Type: 10-Q
Importance Score:
7
UG
May 08, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
8
UG
Apr 06, 2026, 12:02 PM EDT
Filing Type: DEF 14A
Importance Score:
7